STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
Management ChangeApr 21, 2026, 04:07 PM

Lipocine Board Chairman Spyros Papapetropoulos Resigns

AI Summary

Spyros Papapetropoulos resigned from Lipocine Inc.'s Board of Directors on April 16, 2026, citing competing professional commitments and differing views on the company's strategic direction. He had served on the board since 2022, holding positions as Chairman and Lead Independent Director, and was a member of the compensation committee. Following his departure, the Board appointed R. Dana Ono as the new Chairman and Lead Independent Director on April 20, 2026.

Key Highlights

  • Spyros Papapetropoulos resigned from Lipocine's Board on April 16, 2026.
  • He served as Chairman, Lead Independent Director, and compensation committee member since 2022.
  • Reasons for resignation included competing professional commitments and differing strategic views.
  • R. Dana Ono was appointed Chairman of the Board and Lead Independent Director on April 20, 2026.
LPCN
Biotechnology: Pharmaceutical Preparations
Lipocine Inc.

Price Impact